Aberrantly Expressed Mir-582-3p Maintains Lung Cancer Stem Cell-Like Traits by Activating Wnt/β-catenin Signalling

Lishan Fang,Junchao Cai,Baixue Chen,Shanshan Wu,Rong Li,Xiaonan Xu,Yi Yang,Hongyu Guan,Xun Zhu,Le Zhang,Jie Yuan,Jueheng Wu,Mengfeng Li
DOI: https://doi.org/10.1038/ncomms9640
IF: 16.6
2015-01-01
Nature Communications
Abstract:Cancer stem cells (CSCs) are involved in tumorigenesis, tumour recurrence and therapy resistance and Wnt signalling is essential for the development of the biological traits of CSCs. In non-small cell lung carcinoma (NSCLC), unlike in colon cancer, mutations in β-catenin and APC genes are uncommon; thus, the mechanism underlying the constitutive activation of Wnt signalling in NSCLC remains unclear. Here we report that miR-582-3p expression correlates with the overall- and recurrence-free-survival of NSCLC patients, and miR-582-3p has an activating effect on Wnt/β-catenin signalling. miR-582-3p overexpression simultaneously targets multiple negative regulators of the Wnt/β-catenin pathway, namely, AXIN2, DKK3 and SFRP1. Consequently, miR-582-3p promotes CSC traits of NSCLC cells in vitro and tumorigenesis and tumour recurrence in vivo. Antagonizing miR-582-3p potently inhibits tumour initiation and progression in xenografted animal models. These findings suggest that miR-582-3p mediates the constitutive activation of Wnt/β-catenin signalling, likely serving as a potential therapeutic target for NSCLC.
What problem does this paper attempt to address?